Paul G. Allen Frontiers Group

From Wikipedia, the free encyclopedia

The Paul G. Allen Frontiers Group is a bioscience research initiative started in 2016 funded with an initial investment of $100 million. Its new vision is to identify areas in bioscience that are ripe for a major breakthrough, and then fund specific investigators to pursue advances.[1][2]

References[]

  1. ^ "Microsoft pioneer invests big, again, in bioscience". Sciencemag.org. Retrieved March 24, 2016.
  2. ^ "Paul G. Allen Announces $100 Million to Launch the Paul G. Allen Frontiers Group". PRNewswire. 23 March 2016. Retrieved 29 October 2017.


Retrieved from ""